BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lymphocyte
,
Metabolism of nitric oxide
,
Cisplatin
,
rs3825942
,
IL1A
,
Lung cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cyclic s- oxides
Summary
General Info
Curated Studies
Most Correlated Studies
Pancreatic ductal adenocarcinoma xenografts compared based on resistance or sensitivity to MRK-003
Thymic lymphoma T29 cells, Ikaros deficient, treated with G-secretase inhibitor (MRK003)
Wildtype and IKAROS-deficient DN3 cells treated with gamma secretase inhibitor
LTED cells treated with gamma-secretase inhibitor or depleted of PBX1
GSI response in triple negative breast cancer and adenoid cystic carcinoma cell lines
Explore Curated Studies Results
Literature
Most Relevant Literature
Neurotoxicity of ischemic astrocytes involves STAT3-mediated metabolic switching and depends on glyc…
Small-molecule positive allosteric modulation of homomeric kainate receptors GluK1-3: development of…
The positive allosteric modulator BPAM344 and L-glutamate introduce an active-like structure of the …
A Model-Based Approach to Bridging Plasma and Dried Blood Spot Concentration Data for Phase 3 Verube…
Enantiomeric separation of oxomemazine in rabbit plasma by ultra-fast LC and application in a stereo…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for cyclic s- oxides
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ